DK1778860T3 - Fremgangsmåde til bestemmelse af styrke, specificiteten og toksiciteten af hæmapoietisk prostaglandin D2 systase - Google Patents
Fremgangsmåde til bestemmelse af styrke, specificiteten og toksiciteten af hæmapoietisk prostaglandin D2 systaseInfo
- Publication number
- DK1778860T3 DK1778860T3 DK05781699T DK05781699T DK1778860T3 DK 1778860 T3 DK1778860 T3 DK 1778860T3 DK 05781699 T DK05781699 T DK 05781699T DK 05781699 T DK05781699 T DK 05781699T DK 1778860 T3 DK1778860 T3 DK 1778860T3
- Authority
- DK
- Denmark
- Prior art keywords
- potency
- specificity
- toxicity
- prostaglandin
- systasis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/533—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Ecology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59250104P | 2004-07-30 | 2004-07-30 | |
| PCT/US2005/026945 WO2006015195A1 (fr) | 2004-07-30 | 2005-07-28 | Methodes pour determiner la puissance, la specificite et la toxicite de la prostaglandine d2 synthase hematopoietique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1778860T3 true DK1778860T3 (da) | 2008-05-13 |
Family
ID=35115717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05781699T DK1778860T3 (da) | 2004-07-30 | 2005-07-28 | Fremgangsmåde til bestemmelse af styrke, specificiteten og toksiciteten af hæmapoietisk prostaglandin D2 systase |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070259384A1 (fr) |
| EP (1) | EP1778860B1 (fr) |
| JP (1) | JP2008507980A (fr) |
| KR (1) | KR20070046830A (fr) |
| CN (1) | CN1993479A (fr) |
| AT (1) | ATE384136T1 (fr) |
| AU (1) | AU2005267920A1 (fr) |
| BR (1) | BRPI0512645A (fr) |
| CA (1) | CA2575523A1 (fr) |
| DE (1) | DE602005004420T2 (fr) |
| DK (1) | DK1778860T3 (fr) |
| ES (1) | ES2297753T3 (fr) |
| IL (1) | IL180837A0 (fr) |
| MX (1) | MX2007000043A (fr) |
| WO (1) | WO2006015195A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2722420A1 (fr) | 2008-05-13 | 2009-11-19 | Cayman Chemical Company, Incorporated | Procedes d'evaluation de la capacite de composes ou d'agents a deplacer de puissants ligands de la prostaglandine d synthase hematopoietique |
| CN111549000B (zh) * | 2020-06-18 | 2022-07-29 | 中国医学科学院整形外科医院 | 一种过表达Hpgds的重组脂肪干细胞、制备方法及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3600847B2 (ja) * | 1996-06-05 | 2004-12-15 | 財団法人大阪バイオサイエンス研究所 | ヒトの造血器型プロスタグランジンｄ合成酵素をコードするｄｎａ |
| GB0229244D0 (en) * | 2002-08-16 | 2003-01-22 | Aventis Pharma Inc | Method for assaying compounds for inhibition of the activity of prostaglandin synthase |
| GB2410025B (en) * | 2002-10-03 | 2007-03-28 | Inst Med Molecular Design Inc | Quinazolin-4-one derivatives |
-
2005
- 2005-07-28 CN CNA2005800258328A patent/CN1993479A/zh active Pending
- 2005-07-28 KR KR1020077002332A patent/KR20070046830A/ko not_active Application Discontinuation
- 2005-07-28 ES ES05781699T patent/ES2297753T3/es active Active
- 2005-07-28 AT AT05781699T patent/ATE384136T1/de not_active IP Right Cessation
- 2005-07-28 US US11/569,146 patent/US20070259384A1/en not_active Abandoned
- 2005-07-28 JP JP2007523838A patent/JP2008507980A/ja active Pending
- 2005-07-28 DK DK05781699T patent/DK1778860T3/da active
- 2005-07-28 AU AU2005267920A patent/AU2005267920A1/en not_active Abandoned
- 2005-07-28 WO PCT/US2005/026945 patent/WO2006015195A1/fr active IP Right Grant
- 2005-07-28 MX MX2007000043A patent/MX2007000043A/es active IP Right Grant
- 2005-07-28 EP EP05781699A patent/EP1778860B1/fr active Active
- 2005-07-28 BR BRPI0512645-2A patent/BRPI0512645A/pt not_active IP Right Cessation
- 2005-07-28 DE DE602005004420T patent/DE602005004420T2/de not_active Expired - Fee Related
- 2005-07-28 CA CA002575523A patent/CA2575523A1/fr not_active Abandoned
-
2007
- 2007-01-21 IL IL180837A patent/IL180837A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL180837A0 (en) | 2007-06-03 |
| EP1778860B1 (fr) | 2008-01-16 |
| US20070259384A1 (en) | 2007-11-08 |
| DE602005004420D1 (de) | 2008-03-06 |
| WO2006015195A1 (fr) | 2006-02-09 |
| ATE384136T1 (de) | 2008-02-15 |
| CA2575523A1 (fr) | 2006-02-09 |
| KR20070046830A (ko) | 2007-05-03 |
| CN1993479A (zh) | 2007-07-04 |
| MX2007000043A (es) | 2007-03-27 |
| JP2008507980A (ja) | 2008-03-21 |
| EP1778860A1 (fr) | 2007-05-02 |
| AU2005267920A1 (en) | 2006-02-09 |
| BRPI0512645A (pt) | 2008-03-25 |
| DE602005004420T2 (de) | 2009-01-08 |
| WO2006015195A8 (fr) | 2006-12-21 |
| ES2297753T3 (es) | 2008-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY29479A1 (es) | Inhibidores de adn-pk | |
| EA200701257A1 (ru) | Пирролопиразолы в качестве сильнодействующих ингибиторов киназы | |
| CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
| UY29612A1 (es) | Compuestos quimicos ii | |
| GB2451042A (en) | Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds and other chemicals | |
| DK1761520T3 (da) | Kinaseinhibitorer | |
| MY144590A (en) | Glutamate aggrecanase inhibitors | |
| CR11618A (es) | Inhibidores macrocíclicos de serina proteasa | |
| EA200601701A1 (ru) | Ингибиторы дипептидилпептидазы | |
| NO20080761L (no) | Acykliske Ikur inhibitorer | |
| SV2006002232A (es) | Inhibidores bace ref. x-16940 | |
| SV2006002001A (es) | Inhibidores de quinasa ref. x - 16437 | |
| CL2012003104A1 (es) | Compuestos derivados de multiheteroarilos, inhibidores de prostaglandina d sintasa hematopoyetica (h-pgds); y composicion farmaceutica que los comprende. | |
| TR200705187T1 (tr) | 2-Kromen hazırlanması için yeni yöntemler | |
| EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
| ATE417849T1 (de) | Pyrazoloä4,3-düpyrimidine | |
| DE112005003431A5 (de) | Neuartige Inhibitoren der Lysyloxidase | |
| NO20080468L (no) | Diazepinokinoliner, synteser av disse samt intermediater | |
| SE0103710D0 (sv) | Compounds | |
| DE60336475D1 (de) | Ät | |
| TW200801015A (en) | Substituted aminophenylsulfonamide compounds as HIV protease inhibitor | |
| NO20082185L (no) | Heterocykliske CETP-inhibitorer | |
| DK1778860T3 (da) | Fremgangsmåde til bestemmelse af styrke, specificiteten og toksiciteten af hæmapoietisk prostaglandin D2 systase | |
| DE602005023528D1 (de) | Piperidinderivate als prodrugs von kaliumkanalinhibitoren | |
| DE60324388D1 (de) | Fluorogene farbstoffe |